Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Salzman

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cell|December 1, 1982
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNAJ Brady, M Radonovich, M Vodkin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160M B Vasudevachari, K W Uffelman, J Kovacs, et al.
Journal of Virology|September 1, 1997
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sitesY M Zhang, H Imamichi, T Imamichi, et al.
Journal of Clinical Microbiology|January 1, 1989
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysisM B Vasudevachari, K W Uffelman, T C Mast, et al.
Journal of Virology|November 1, 1989
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individualsM C Psallidopoulos, S M Schnittman, L M Thompson, et al.
Annals of Internal Medicine|September 15, 1990
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical diseaseS M Schnittman, J J Greenhouse, M C Psallidopoulos, et al.
Journal of Clinical Immunology|May 1, 1993
Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assayM B Vasudevachari, N P Salzman, D R Woll, et al.
Science (New York, N.Y.)|July 21, 1989
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4S M Schnittman, M C Psallidopoulos, H C Lane, et al.
Annals of Internal Medicine|July 1, 1989
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trialH C Lane, J Falloon, R E Walker, et al.
Virology|September 1, 1992
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitorsM B Vasudevachari, C Battista, H C Lane, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cell|December 1, 1982
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNAJ Brady, M Radonovich, M Vodkin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160M B Vasudevachari, K W Uffelman, J Kovacs, et al.
Journal of Virology|September 1, 1997
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sitesY M Zhang, H Imamichi, T Imamichi, et al.
Journal of Clinical Microbiology|January 1, 1989
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysisM B Vasudevachari, K W Uffelman, T C Mast, et al.
Journal of Virology|November 1, 1989
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individualsM C Psallidopoulos, S M Schnittman, L M Thompson, et al.
Annals of Internal Medicine|September 15, 1990
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical diseaseS M Schnittman, J J Greenhouse, M C Psallidopoulos, et al.
Journal of Clinical Immunology|May 1, 1993
Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assayM B Vasudevachari, N P Salzman, D R Woll, et al.
Science (New York, N.Y.)|July 21, 1989
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4S M Schnittman, M C Psallidopoulos, H C Lane, et al.
Annals of Internal Medicine|July 1, 1989
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trialH C Lane, J Falloon, R E Walker, et al.
Virology|September 1, 1992
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitorsM B Vasudevachari, C Battista, H C Lane, et al.
Pageof 7